As far this aspect of the literature is considered there is an intense relationship between visceral metastasis and BRCA1/2 mutation carriers for that reason BRCA1/2 mutation analysis should be performed for ovarian cancer patients who develop visceral metastasis [12]. Here, BRCA1 is linked to ovarian cancer.